Skip to main content
Premium Trial:

Request an Annual Quote

Courtagen Spotlight Genetic Tests for Neuromuscular Disorders

Courtagen Life Sciences has launched an expansion of its Spotlight test menu in neurology and endocrinology. The 10 new gene panels increase the company's selection of tests available for epilepsy, developmental delay, endocrinology, and mitochondrial disease. They primarily address neuromuscular disorders, such as congenital myasthenia, hereditary spastic paraplegia, congenital and limb-girdle muscular dystrophy, and myopathies, and one new endocrine disorder test for Bardet Biedl syndrome.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.